Reyon Pharmaceutical Co. Ltd. (102460) Stock Forecast & Analysis
Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Reyon Pharmaceutical Co. Ltd. (102460:KRX), powered by AI.
- Current Price
- ₩9,920
- P/E Ratio
- -6.2
- Market Cap
- 184.4B
- Sector
- Healthcare
What is the Reyon Pharmaceutical Co. Ltd. stock price forecast?
Reyon Pharmaceutical Co. Ltd. is currently trading at ₩9,920. View real-time AI analysis on Alpha Lenz.
What is Reyon Pharmaceutical Co. Ltd. insider trading activity?
View the latest insider trading data for Reyon Pharmaceutical Co. Ltd. on Alpha Lenz.
What is Reyon Pharmaceutical Co. Ltd.'s P/E ratio?
Reyon Pharmaceutical Co. Ltd.'s P/E ratio is -6.2.
Reyon Pharmaceutical Co. Ltd.
KRX · 102460“Reyon Pharmaceutical Co. Ltd. trades at a P/E of -6.2 (undervalued) with modest ROE of -12.6%.”
Ask for details →Company Overview
Reyon Pharmaceutical Co. Ltd. is a dynamic enterprise in the pharmaceutical industry, focused on the development, manufacturing, and distribution of pharmaceutical and healthcare products. The company specializes in a broad portfolio that includes active pharmaceutical ingredients, generic drugs, and innovative therapies, aiming to enhance patient well-being by providing high-quality and affordable healthcare solutions. Notable for its commitment to research and development, Reyon Pharmaceutical continuously invests in cutting-edge technologies and collaborations to advance its product offerings. Its operations significantly impact sectors such as healthcare providers, hospitals, and retail pharmacies, contributing to the accessibility of essential medications across various communities. Headquartered in South Korea, Reyon Pharmaceutical plays a crucial role in the global pharmaceutical supply chain, demonstrating influence through its strategic market presence and continual pursuit of medical advancements.
Company Statistics
FY 2025Profile
Margins
Valuation
Growth (CAGR)
Returns
Financial Health
“Reyon Pharmaceutical Co. Ltd. trades at a P/E of -6.2 (undervalued) with modest ROE of -12.6%.”
Ask for details →Frequently Asked Questions
Reyon Pharmaceutical Co. Ltd. (ticker: 102460) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 448 employees. Market cap is $184.4B.
The current price is ₩9,920 with a P/E ratio of -6.22x and P/B of 0.84x.
ROE is -12.60% and operating margin is -21.03%. Annual revenue is $145.9B.